Highlights of the 83rd European Atherosclerosis Society (EAS) annual Congress, Glasgow 22-25 March, 2015

Atherosclerosis. 2015 Sep;242(1):45-7. doi: 10.1016/j.atherosclerosis.2015.06.039. Epub 2015 Jun 20.
No abstract available

Publication types

  • Congress

MeSH terms

  • Atherosclerosis / diagnostic imaging
  • Atherosclerosis / drug therapy
  • Atherosclerosis / etiology
  • Atherosclerosis / prevention & control*
  • Cardiovascular Agents / therapeutic use
  • Cholesterol, LDL / blood
  • Consensus Development Conferences as Topic
  • Europe
  • Humans
  • Hypolipidemic Agents / therapeutic use
  • Life Style
  • Lipoprotein(a) / antagonists & inhibitors
  • Molecular Targeted Therapy
  • Oligonucleotides, Antisense / therapeutic use
  • Practice Guidelines as Topic
  • Precision Medicine / methods
  • Precision Medicine / trends
  • Proprotein Convertase 9
  • Proprotein Convertases / antagonists & inhibitors
  • Radionuclide Imaging
  • Risk Factors
  • Scotland
  • Sedentary Behavior
  • Serine Endopeptidases
  • Smoking / adverse effects
  • Societies, Medical

Substances

  • Cardiovascular Agents
  • Cholesterol, LDL
  • Hypolipidemic Agents
  • Lipoprotein(a)
  • Oligonucleotides, Antisense
  • PCSK9 protein, human
  • Proprotein Convertase 9
  • Proprotein Convertases
  • Serine Endopeptidases